Prognostic factors for pulmonary embolism: The PREP study, a prospective multicenter cohort study

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 2, 2010, Pages 168-173

  Sanchez, Olivier ^a   Trinquart, Ludovic ^b   Caille, Vincent ^c   Couturaud, Francis ^c,d   Pacouret, Gérard ^c   Meneveau, Nicolas ^e   Verschuren, Franck ^f   Roy, Pierre Marie ^g   Parent, Florence ^c   Righini, Marc ^h   Perrier, Arnaud ^h   Lorut, Christine ^c   Tardy, Bernard ^c   Benoit, Marie Odile ^c   Chatellier, Gilles ^b   Meyer, Guy ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Universite de Brest   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g ANGERS UNIVERSITY HOSPITAL   (France)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Echocardiography; Natriuretic peptides; Prognosis; Pulmonary embolism

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTICOAGULANT AGENT; BRAIN NATRIURETIC PEPTIDE; FIBRINOLYTIC AGENT; TROPONIN I;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY DIAMETER; ARTICLE; CARDIOGENIC SHOCK; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBOLECTOMY; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE MASS; HEART RIGHT VENTRICLE; HEART SIZE; HEMODYNAMIC PARAMETERS; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOPLASM; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; AGED; CAUSE OF DEATH; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECURRENCE; RISK ASSESSMENT; SHOCK, CARDIOGENIC; SURVIVAL RATE; TROPONIN I; VENOUS THROMBOEMBOLISM;

EID: 74949103937     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200906-0970OC     Document Type: Article

References (13)

1. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-1389.
2. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 2004;140:175-183.
3. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041-1046.
4. Donze J, Le Gal G, Fine MJ, Roy PM, Sanchez O, Verschuren F, Cornuz J, Meyer G, Perrier A, Righini M, et al. Prospective validation of the pulmonary embolism severity index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008;100:943-948.
5. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007;116:427-433.
6. Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med 2008;178:425-430.
7. Sanchez O, Trinquart L, Colombet I, Durieux P, Huisman MV, Chatellier G, Meyer G. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008;29:1569-1577.
8. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276-2315.
9. Kearon C, Kahn SR, Agnelli G, Goldhaber SZ, Raskob G, Comerota J. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:454-545.
10. Heinze G, Schemper M. Comparing the importance of prognostic factors in Cox and logistic regression using SAS. Comput Methods Programs Biomed 2003;71:155-163.
11. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172, discussion 207-212.
12. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004;23:1631-1660.
13. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172.